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SHORT ABSTRACT:  45 
 46 
Bacterial attachment to host cells is a key step during host colonization and infection. This 47 
protocol describes the generation of polymer-coupled recombinant adhesins as biomimetic 48 
materials which allow analysis of the contribution of individual adhesins to these processes, 49 
independent of other bacterial factors.  50 
 51 
LONG ABSTRACT:  52 
 53 
Bacterial attachment to host cells is one of the earliest events during bacterial colonization of 54 
host tissues and thus a key step during infection. The biochemical and functional 55 
characterization of adhesins mediating these initial bacteria-host interactions is often 56 
compromised by the presence of other bacterial factors, such as cell wall components or 57 
secreted molecules, which interfere with the analysis. This protocol describes the production 58 
and use of biomimetic materials, consisting of pure recombinant adhesins chemically coupled 59 
to commercially available, functionalized polystyrene beads, which have been used successfully 60 
to dissect the biochemical and functional interactions between individual bacterial adhesins 61 
and host cell receptors. Protocols for different coupling chemistries, allowing directional 62 
immobilization of recombinant adhesins on polymer scaffolds, and for assessment of the 63 
coupling efficiency of the resulting “bacteriomimetic” materials are also discussed. We further 64 
describe how these materials can be used as a tool to inhibit pathogen mediated cytotoxicity 65 
and discuss scope, limitations and further applications of this approach in studying bacterial - 66 
host interactions. 67 
 68 
INTRODUCTION:  69 
 70 
Dissecting the interactions between bacterial adhesins and host surface receptors at the host-71 
pathogen interface is an essential step towards our understanding of the underlying 72 
mechanisms driving bacterial adhesion. Ultimately, this will help us to identify strategies to 73 
interfere with these processes during infections. In conducting such studies, we often face a 74 
dilemma: Biochemical and biophysical analysis of the molecular mechanisms of adhesin binding 75 
requires their separation from other cell wall components, which may interfere with adhesion 76 
events. On the other hand, the use of recombinant soluble proteins over-simplifies the 77 
adhesion event, by disregarding protein anchoring in the bacterial cell wall and multivalency of 78 
binding achieved through bacterial surface display. Equally, from the host cell’s perspective, 79 
encountering and binding to single adhesin molecules does not always have the same impact in 80 
terms of plasma membrane organization, membrane fluidity and receptor clustering1 and this, 81 
ultimately, makes it difficult to evaluate the impact of adhesion on host cellular signaling and 82 
the outcome of bacteria-host interactions.  83 
 84 
Recently a method was devised, whereby recombinant purified adhesins or adhesin fragments 85 
are directionally and covalently coupled to polymer particles similar in size to bacteria, thus 86 
mimicking bacterial surface display. This approach has been used on a range of different 87 
adhesins, from Gram-negative Multivalent Adhesion Molecules (MAMs)2, 3, to Gram-positive 88 
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adhesins including Staphylococcus aureus fibronectin binding protein (FnBPA)4, 5 and 89 
Streptococcus pyogenes F1 6, 7. This method has allowed the dissection of adhesin fragments 90 
important for host cell binding, identification of host surface receptors and determination of 91 
their behavior on the host cell surface, while taking both binding affinity and avidity into 92 
consideration 1, 8. Additionally, this approach has been used to investigate the efficacy of 93 
immobilized adhesins and derivatives as inhibitors of host-pathogen interactions 8, 9. It has been 94 
demonstrated that surface coupled derivatives of the Vibrio parahaemolyticus Multivalent 95 
Adhesion Molecule (MAM) 7 can be used to attenuate a range of bacterial infections in vitro, 96 
including those caused by multidrug-resistant pathogens such as Acinetobacter baumannii and 97 
methicillin-resistant S. aureus (MRSA) 7, 9.  98 
 99 
Herein, we describe different chemistries which can be used to immobilize adhesins to 100 
commercially available functionalized polystyrene particles. Due to the wide array of available 101 
surface functionalities, labels and particle sizes, these are a useful scaffold for the production of 102 
bacteriomimetic materials to investigate adhesin-host interactions. We further describe 103 
methods for the initial characterization of the coupling reaction, and for the calculation of 104 
important properties of the resulting materials. Finally, the use of bead-coupled adhesins as 105 
competitive inhibitors of in vitro bacterial infections is discussed as an example of their 106 
application, as well as the future scope and limitations of this approach. 107 
 108 
PROTOCOL:  109 
 110 
1. Chemical coupling of proteins to polymer beads 111 
 112 
1.1. Thiol-amine directional coupling 113 
 114 
Note: This protocol is suitable for coupling of cysteine containing proteins to amine-115 
functionalized polymer beads, using Sulfosuccinimidyl 4-(p-maleimidophenyl)butyrate (Sulfo-116 
SMPB) as cross-linking agent (Figure 1). 117 
 118 
[Place Figure 1 here] 119 
 120 
1.1.1 Preparation of reagents: 121 
 122 
1.1.1.1 Prepare PBS (100 mM sodium phosphate, 150 mM NaCl, pH 7.0) and autoclave. 123 
 124 
1.1.1.2 Prepare a 100x stock (0.5 M or 287 mg/ml in PBS) of TCEP (tris(2-125 
carboxyethyl)phosphine) immediately before use.  126 
 127 
1.1.1.3 Prepare a 5x stock (10 mM or 4.58 mg/ml in dH2O) of Sulfo-SMPB immediately prior to 128 
use.  129 
 130 
1.1.1.4 Prepare a 10x stock (500 mM or 88 mg/ml in PBS, pH 7.0) of cysteine immediately 131 
before use. 132 
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 133 
1.1.2 Bead activation: 134 
 135 
1.1.2.1 Mix the bead suspension by gently inverting and transfer the required amount of bead 136 
suspension (e.g., 12 l) into a sterile 1.5 ml tube containing 1 ml sterile PBS, pH 7.0. 137 
1.1.2.2 Gently pipette up and down to wash the beads and pellet by centrifugation in a 138 
microcentrifuge (2 minutes at 16000 x g). 139 
1.1.2.3 Carefully remove the supernatant with a pipette and discard. 140 
1.1.2.4 Resuspend the bead pellet in 1 ml of fresh sterile PBS and repeat the washing step. 141 
1.1.2.5 Resuspend the bead pellet in 0.8 ml of PBS. 142 
1.1.2.6 Add 200 l of freshly prepared 10 mM Sulfo-SMPB, to give a final concentration of 2 143 
mM. 144 
1.1.2.7 Incubate the bead suspension for 1 hour at 25 °C on a rotating wheel. 145 
1.1.3 Protein reduction: 146 
1.1.3.1 During the incubation period of the activation step, prepare the protein for the 147 
following coupling step so it can be immediately added to the activated beads. 148 
Note: Although this reduction step is not always required for GST (Glutathione S-transferase) 149 
fusion proteins, it is recommended to ensure a high coupling efficiency. 150 
1.1.3.1.1 Check the protein concentration, and adjust it to the final concentration required 151 
for the coupling reaction. Note: 6 M protein in PBS, and a volume of 1 ml are usually used.  152 
1.1.3.1.2 Add TCEP stock to give a final concentration of 5 mM. 153 
1.1.3.1.3 Incubate the solution for 30 minutes at room temperature.  154 
Note: The reaction mixture can be directly used for the following coupling reaction. 155 
1.1.3.1.4 Retain a small amount (a few l) of the protein solution for determining the 156 
protein concentration and calculation of coupling efficiency (see section 2).  157 
1.1.4 Protein coupling step: 158 
1.1.4.1 Pellet the activated beads by centrifugation (2 minutes, 16000 x g in a microcentrifuge), 159 
and wash the pellet once in 1 ml of fresh sterile PBS. 160 
1.1.4.2 Resuspend the pellet in the prepared protein solution (e.g., 1 ml), to give the desired 161 
protein concentration.  162 
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Note: The protein concentration during the coupling step will depend on the average coupling 163 
efficiency (see section 2 for determination of the coupling efficiency) and desired coupling 164 
density (as calculated in 1.1.4.3). The efficiency is approximately 85% and the desired final 165 
concentration 5 M in the 10x bead suspension, so protein concentration during the coupling 166 
step should be approximately 6 M. 167 
1.1.4.3 Calculate the coupling density using the following formula: 168 
 169 
                    
             
          
 
      
          
 
 
   
  
 170 
where 171 
 172 
c   coupling density [number of protein molecules/nm
2], 173 
protein conc protein concentration [mg/ml], 174 
protein Mw protein molecular weight [Da], 175 
bead conc bead concentration [number of beads/L], 176 
d  bead diameter [nm2] 177 
       Avogadro’s number 178 
 179 
1.1.4.4 Use the coupling density to calculate the average ligand spacing: 180 
 181 
                              
 
  
 
1.1.4.5 Incubate the protein-bead suspension for 2 hours at 25 °C on a rotating wheel.  182 
Note: Some proteins may not be stable at room temperature. In these cases, the reaction can 183 
be carried out at 4 °C overnight. 184 
1.1.4.6 Deactivate remaining activated groups on the beads by adding cysteine stock to a final 185 
concentration of 50 mM and incubate the suspension for 30 minutes at 25 °C on a rotating 186 
wheel. 187 
1.1.4.7 Pellet the beads by centrifugation (2 minutes, 16000 x g in a microcentrifuge).  188 
1.1.4.8 Keep the supernatant for determining the protein concentration and calculation of 189 
coupling efficiency (see section 2).  190 
1.1.4.9 Wash the bead pellet twice with 1 ml PBS and resuspend in 1 ml fresh PBS to give the 191 
final product. 192 
Note: The above protocol will typically give 1 ml of coupled protein, at a final concentration of 5 193 
M protein, which can be used as a 10x stock for subsequent experiments (see section 3).  194 
1.1.4.10 To proceed to section 3 of the protocol, work with 100 l/ml of bead stock, or at a final 195 
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concentration of 500 nM protein. Note: A good starting point for this procedure will be 21012 196 
beads/ml, resulting in an average coupling density of 310-4 proteins/nm2 or an average spacing 197 
of 57 nm on a bead of 2 m diameter.  198 
1.2. Thiol-carboxy directional coupling 199 
 200 
Note: This protocol is suitable for coupling cysteine containing proteins to carboxyl-201 
functionalized polystyrene beads. The carboxyl moiety is first activated using 1-Ethyl-3-(3-202 
dimethylaminopropyl)carbodiimide (EDC)/ N-hydroxysuccinimide (NHS), amine modified and 203 
then cross-linked using Sulfo-SMPB (Figure 2).  204 
 205 
[Place Figure 2 here] 206 
 207 
1.2.1 Preparation of reagents: 208 
 209 
1.2.1.1 Prepare PBS (100 mM sodium phosphate, 150 mM NaCl, pH 7.0) and autoclave. 210 
 211 
1.2.1.2 Prepare a 100x stock (0.5 M or 287 mg/ml in PBS,) of TCEP immediately before use. 212 
 213 
1.2.1.3 Prepare a 10x stock (20 mM, or 4 mg/ml in PBS) of EDC (1-Ethyl-3-(3-214 
dimethylaminopropyl)carbodiimide) immediately before use. 215 
 216 
1.2.1.4Prepare a 10x stock (50 mM, or 6 mg/ml in PBS) of NHS (N-hydroxysuccinimide) 217 
immediately prior to use. 218 
 219 
1.2.1.5 Prepare a 5x stock (10 mM or 4.58 mg/ml in dH2O) of Sulfo-SMPB immediately prior to 220 
use.  221 
 222 
1.2.1.6 Prepare a 10x stock (500 mM or 88 mg/ml in PBS, pH 7.0) of cysteine immediately 223 
before use. 224 
 225 
1.2.2 Bead activation: 226 
 227 
1.2.2.1 Mix bead suspension by gently inverting and transfer the required amount of bead 228 
suspension (e.g., 12 l) into a sterile 1.5 ml tube containing 1 ml sterile PBS, pH 7.0. 229 
1.2.2.2 Gently pipette up and down to wash the beads and pellet by centrifugation in a 230 
microcentrifuge (2 minutes at 16000 x g). 231 
1.2.2.3 Carefully remove the supernatant with a pipette and discard. 232 
1.2.2.4 Resuspend the bead pellet in 1 ml of fresh sterile PBS and repeat the washing step. 233 
1.2.2.5 Resuspend the bead pellet in 0.8 ml of PBS. 234 
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1.2.2.6 Add 100 l of 10x EDC stock (2 mM final concentration) and immediately 100 l of 10x 235 
NHS stock solution (5 mM final concentration) to the bead suspension.  236 
1.2.2.7 Incubate the bead suspension for 30 minutes at 25 °C on a rotating wheel. 237 
1.2.2.8 Wash beads once in 1 ml of PBS and resuspend in 0.8 ml fresh sterile PBS. 238 
1.2.2.9 Add 200 l ethylenediamine, and incubate the bead suspension for 1 hour at 25 °C on a 239 
rotating wheel. 240 
1.2.2.10 Wash beads once with 1 ml PBS and resuspend the beads in 0.8 ml of fresh PBS. 241 
1.2.2.11 Proceed from section 1.1.2.6 (bead activaton with Sulfo-SMPB) as described 242 
under section 1.1.2 and follow the rest of the protocol described in section 1.1 (Thiol-amine 243 
directional coupling). Perform protein preparation and protein coupling steps in a manner 244 
identical to those described in section 1.1.  245 
Note: The typical coupling efficiency using this protocol is slightly lower (approx. 75%) 246 
compared to section 1.1, therefore adjust the initial protein concentration accordingly to 247 
achieve the same coupling density.  248 
2. Determination of coupling efficiency 249 
Note: To determine protein concentration, use Bradford Reagent 10 and colorimetric assays as 250 
follows: 251 
2.1 Gently invert Bradford Reagent to ensure homogeneity of the reagent. 252 
2.2 Using a 10 mg/ml BSA stock solution, prepare protein standards covering concentrations 253 
from 0.1 to 1.5 mg/ml BSA in buffer. 254 
2.3 Add 250 l of Bradford Reagent to wells of a 96-well plate. Prepare enough wells for all 255 
samples, protein standards and negative controls (buffer only). 256 
2.4 Add 5 l of protein sample (protein standards or buffer, for the negative control) to the 257 
reagent in the 96-well plate.  258 
2.5 Incubate the plate on an orbital shaker at room temperature for 10 minutes. 259 
2.6 Measure absorbance at 595 nm using a plate reader.  260 
2.7 Generate a standard curve of BSA concentration versus A595nm and use this to 261 
determine protein concentrations in initial and supernatant samples. 262 
2.8 Calculate the concentration of coupled protein as follows: 263 
 264 
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 265 
2.9 Calculate the coupling efficiency as: 266 
 267 
                          
                                       
                 
       268 
  269 
  270 
3. Use of bead-coupled adhesins in competition assays 271 
3.1 Preparation: 272 
3.1.1 Seed 1 ml per well of Hela cells at a concentration of 150000 cells/ml into a 24-well 273 
plate the day before the competition assay, to allow cells to reach approximately 80% 274 
confluency prior to starting the experiment.  275 
3.1.2 Set up each experimental condition in triplicate. Include wells for negative controls (no 276 
bacteria added during competition assays), positive controls (control beads coupled to fusion-277 
tag only added during competition assays) and lysis controls (for cytotoxicity experiments).  278 
3.1.3 Inoculate a 5 ml marine LB (MLB) culture with a fresh colony of V. parahaemolyticus and 279 
grow overnight at 30 °C, shaking.  280 
3.1.4 Prepare sufficient bead-coupled MAM, as described in section 1. (Coupling). Allow for 281 
100 l of 10x bead stock per well. 282 
3.2 Competition assay: 283 
3.2.1 On the day of the competition experiment, measure the OD600 of the bacterial culture. 284 
3.2.2 Prepare infection media by diluting bacterial cultures into colorless DMEM without 285 
additives, pre-warmed to 37 °C, containing 10% v/v bead suspension (either adhesin-coupled 286 
beads or control beads), to give an MOI of 10. Prepare 1 ml/well and 10-20% excess volume per 287 
sample.  288 
Note: For the above mentioned conditions (24-well plate, V. parahaemolyticus, MOI 10), the 289 
necessary volume of overnight culture to be added per well (l/ml) is calculated as 3/OD600 of 290 
the culture. For example, 1 ml of infection medium will typically contain 100 l bead 291 
suspension, a few l of bacterial culture and be made up to 1 ml with colorless, 292 
unsupplemented DMEM. 293 
3.2.3 Remove old medium from wells and wash cultured Hela cells by adding 1 ml of sterile 294 
PBS pre-warmed to 37 °C to each well.  295 
3.2.4 Remove PBS and add 1 ml of infection medium per well. Also set up controls, by adding 296 
solutions containing control beads and bacteria (positive control) or adhesin beads and no 297 
   
9 
 
bacteria (negative controls), or DMEM containing 0.1% Triton X-100 (lysis control, only 298 
necessary for cytotoxicity measurements). 299 
3.2.5 Incubate the plate in a tissue culture incubator at 37 °C for the desired amount of time 300 
(e.g. 4 hours for cytotoxicity measurements or 1 hour for adhesion measurements).  301 
Note: Both bacterial adhesion and cytotoxicity on host cells can be used as read-outs for the 302 
efficacy of inhibition. If the time points of cytotoxicity and adhesion measurements coincide, 303 
both assays may be performed using samples from the same well, since cytotoxicity is 304 
determined using the culture supernatant and attachment assays use samples derived from the 305 
remaining cell layer. 306 
3.3 Cytotoxicity measurements: 307 
3.3.1 At indicated time points (e.g., 4 hours post infection), remove three times 200 l from 308 
each 24-well and transfer to a 96-well plate. 309 
3.3.2 Spin 96-well plates at 1500 x g, 5minutes and transfer 100 l from each well into a fresh 310 
96-well plate. 311 
 312 
3.3.3 Add 100 l of the media used during infection experiments to fresh wells of the 96-well 313 
plate in triplicate (these will be used as blanks).  314 
 315 
3.3.4 Carry out the lactate dehydrogenase (LDH) release assay using a LDH cytotoxicity 316 
detection kit and following the manufacturer’s instructions. 317 
 318 
3.3.4.1 Briefly, calculate the amount of reagent needed in increments of 25 (e.g., if 62 samples 319 
are to be measured, make up enough reagent mix for 75 etc.). 320 
 321 
3.3.4.2 For example, for 100 samples, mix 11.25 ml of reagent A with 250 µl of reagent B. 322 
Invert, do not vortex to avoid foaming. 323 
 324 
3.3.4.3 Put the mixture in a reservoir to be able to pipet with a multi-channel pipette.  325 
 326 
3.3.4.4 Add 100 µl of reagent mix to each sample. 327 
 328 
3.3.4.5 Incubate plate at room temperature and read the absorbance at 490 nm on a plate 329 
reader at 10, 20, 30 minutes. 330 
 331 
3.3.4.6 Analyze the data set for which the absorbance of the lysis control sample is high but still 332 
within the linear range of the plate reader (typically, 2-3 absorbance units). 333 
 334 
3.3.4.7 Express results as % cytotoxicity, using the following formula for conversion: 335 
 336 
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 337 
3.4 Measurement of bacterial adhesion: 338 
3.4.1 At indicated time points (e.g., 1 hour post infection), remove media from the cell layer. 339 
3.4.2 Thoroughly wash the cell layer with sterile, pre-warmed PBS (at least 3-4 washes of 1 ml 340 
PBS each) to remove any un-attached cells. 341 
3.4.3 Lyse host cells by adding 1 ml of a sterile 1 % v/v Triton X-100 solution in PBS per well.  342 
3.4.4 Incubate the plate at 37 °C for 5 minutes.  343 
3.4.5 Pipette each sample up and down several times before transferring the contents of each 344 
well to separate 1.5 ml tubes.  345 
3.4.6 Prepare 10-fold serial dilutions of samples into sterile PBS (e.g., use 100 l of sample 346 
and 900 l of PBS). 347 
3.4.7 Plate 100 l of each sample on MLB agar and spread using a cell spreader. Optimize 348 
which dilutions to plate depending on the bacterial strains and time point. Note: For the 349 
described experimental setup, 105 or 106 fold dilutions give a suitable number of CFUs. 350 
3.4.8 Incubate plates at 37 °C overnight and enumerate bacteria by colony counting. 351 
REPRESENTATIVE RESULTS:  352 
 353 
The V. parahaemolyticus adhesin MAM7 contains seven tandem mammalian cell entry (MCE) 354 
domains involved in recognition of host surface receptors. We used polystyrene beads coupled 355 
to recombinant, purified fragments encompassing either all seven tandem MCE domains 356 
(MAM7) or only the first MCE domain (MAM1) to test the ability of these materials to compete 357 
with V. parahaemolyticus for host cell binding and the resulting efficacy of these materials as 358 
adhesion inhibitors. Hela cells were infected with V. parahaemolyticus strain POR1, and 359 
cytotoxicity resulting from in vitro infection was evaluated after 4 hours (Figure 3). Treatment 360 
of Hela cells with 0.1% Triton X-100 (positive lysis control) resulted in complete cell lysis, 361 
uninfected cells displayed very low levels of cytotoxicity.  In vitro infection of untreated cells 362 
with POR1 resulted in very high levels of cell lysis, and this was inhibited by MAM7-coupled 363 
beads but not MAM1-coupled or GST-coupled control beads (Figure 3).  364 
 365 
[Place Figure 3 here] 366 
 367 
Enumeration of V. parahaemolyticus attached to either untreated Hela cells, or cells incubated 368 
with MAM7-, MAM1-, or GST control beads, revealed that MAM7-beads but not  MAM1- or 369 
GST- control beads outcompete V. parahaemolyticus for attachment to host cell surface 370 
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receptors (Figure 4).  371 
 372 
[Place Figure 4 here] 373 
 374 
Adhesins coupled to fluorophore labeled beads result in the generation of materials that mimic 375 
bacterial adhesion to host cells and are powerful tools for cellular imaging (Figure 5). Using 376 
MAM7-coupled fluorescent blue beads, we characterized the process of MAM7-mediated 377 
attachment to epithelial cells. Attachment of MAM7 to host cells resulted in actin 378 
rearrangements and formation of stress fibers, which were co-visualized using rhodamine-379 
phalloidin to stain for F-actin (Figure 5B).  380 
 381 
[Place Figure 5 here] 382 
 383 
Figures & Legends: 384 
 385 
 386 
Figure 1: Cross-linking strategy used for directional thiol-amine coupling of proteins to 387 
polymer beads. Amine-modified polystyrene beads are activated with Sulfo-SMPB. The 388 
maleimide reacts with free cysteines to directionally couple proteins to beads. 389 
 390 
 391 
Figure 2: Cross-linking strategy used for directional thiol-carboxyl coupling of proteins to 392 
polymer beads. Carboxylated polystyrene beads are first activated with EDC and modified with 393 
NHS to form a semi-stable NHS-ester. Subsequent amine-coupling of ethylenediamine results in 394 
a free amine group, which reacts with Sulfo-SMPB. Maleimide activated beads can then react 395 
with free cysteines to directionally couple proteins to beads. 396 
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 397 
 398 
Figure 3. Characterization of Vibrio parahaemolyticus induced cytotoxicity in epithelial cells 399 
during competition assays. Cells were treated with V. parahaemolyticus (V.p), indicated with 400 
(+), or no bacteria (-) in the presence of different competing entities (comp.) as indicated. These 401 
included either no comp. (-), MAM7 beads (MAM7), MAM1 beads (MAM1) or GST control 402 
beads (GST). As controls, cells were treated either with Triton X-100 (triton, lysis control), or left 403 
uninfected (uninf). LDH release after 4 hours was measured as described in section 3, and 404 
results normalized to Triton controls (100 %) and blanks (0 %) as described above. Results are 405 
means ± s.e.m from triplicate experiments.   406 
 407 
 408 
 409 
Figure 4. Characterization of bacterial attachment during competition experiments. Hela cells 410 
were infected with V. parahaemolyticus POR2 (V.p. +), in the absence (-) or presence of 411 
competing entities (comp.) as follows: MAM7 beads (MAM7), MAM1 beads (MAM1) or GST 412 
control beads (GST). Bacterial adhesion was measured after 1 hour, as described in section 3. 413 
Results are means ± s.e.m from triplicate experiments.  Means (f.l.t.r. in CFU/ml) are 2.30106, 414 
1.53105, 2.05106, 2.12106. 415 
 416 
 417 
 418 
Figure 5. Preparation and use of fluorophore labeled biomimetic beads for imaging purposes. 419 
(A) Suspension of fluorescent blue biomimetic beads (right tube, 10x stock) and buffer control 420 
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(left tube). (B) Attachment of MAM7-coupled beads to Hela cells results in actin 421 
rearrangements and stress fiber formation. Attachment of fluorescent blue beads and resulting 422 
actin stress fibers (red, stained with rhodamine-phalloidin) were imaged by microscopy. Bar, 10 423 
m. Images in panel B were adapted from Lim et al.1 and reproduced under the Creative 424 
Commons Attribution license. 425 
 426 
DISCUSSION:  427 
 428 
Herein, we describe two protocols, which can be used to couple thiol-containing proteins to 429 
amine- or carboxylate-modified polystyrene beads, respectively. Due to ease of the procedure, 430 
thiol-amine coupling is preferable, but depending on the desired bead specification (diameter, 431 
fluorescence properties), use of amine-functionalized beads may not be possible and we have 432 
therefore included a protocol which will convert the carboxylate- into an amine moiety to give 433 
the researcher the greatest possible flexibility in choice of scaffold. Although both thiol-amine 434 
and thiol-carboxyl coupling work for any cysteine containing protein, directional coupling (i.e., 435 
immobilization of the protein per its N-terminus, mimicking surface display) requires a protein 436 
without cysteine residues, that is produced as a GST fusion protein, or that contains a single 437 
terminal cysteine residue introduced by site directed mutagenesis. If multiple reactive cysteines 438 
are contained within the protein, this will lead to random immobilization which may impede 439 
protein function. Many bacterial adhesins do not contain cysteines naturally. For others, these 440 
may be removed by site directed mutagenesis, although this would require extensive assays to 441 
ensure native structure and function are retained in the mutant. For GST fusion proteins, 442 
purified GST-tag coupled to beads can be used as a suitable negative control. Using uncoupled 443 
beads as a control should be avoided, as these often have a higher tendency to clump together 444 
or adhere to cells non-specifically. A simplified version of protocol 1.2., using only EDC, can be 445 
used to couple proteins to carboxyl-functionalized polymer beads, however in this case 446 
coupling takes place via primary amines in the protein and therefore does not guarantee 447 
directional coupling.  448 
 449 
TCEP as a reducing agent must not be replaced with other commercially available and 450 
commonly used reducing agents, such as dithiothreitol (DTT) or 2-mercaptoethanol (BME), as 451 
the thiols contained within them will compete with protein coupling in the thiol-maleimide 452 
coupling step. PBS may be replaced with other buffers, but with the following considerations: 453 
Buffers may not contain primary amines (so Tris-containing buffers are not suitable). Use of 454 
buffers containing very low (< 10mM) salt concentrations leads to bead clumping and should 455 
also be avoided. Protein purity is also an important factor to consider during this procedure, 456 
and to achieve high quality data, pure proteins should be used. We routinely purify proteins in 457 
multiple steps, including at least an affinity purification and gel filtration step, but in some cases 458 
ion exchange chromatography is done as a third step. As a result the purity of proteins used for 459 
coupling is usually 90% or higher, as judged by SDS-PAGE.  460 
 461 
It is recommended to determine protein concentrations both in the initial reaction mixture as 462 
well as of the supernatant after reaction completion. This will help to determine the apparent 463 
concentration of bead-coupled protein, and thus coupling density. Determination of both 464 
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values will also allow calculation of the coupling efficiency. This can be taken into account when 465 
preparing the initial protein solution in subsequent reactions, to achieve the desired final 466 
concentration and coupling density. Bradford reagent is particularly suited for determination of 467 
protein concentration before and after the coupling reaction, as none of the substances in the 468 
reaction interferes with the dye complex formation at the concentrations used. If lower protein 469 
concentrations are to be used, this method may have to be replaced by a more sensitive 470 
detection method, however attention has to be paid to the fact it has to be compatible with the 471 
substances contained within the coupling reaction. It is also recommended to use freshly 472 
prepared reagents and handle powdered reagents with care (eg, store in a sealed container and 473 
use silica beads, to avoid the reagents drawing moisture) since the quality of reagents will 474 
influence the coupling efficiency. If the coupling efficiency is lower than expected, possible 475 
remedies include increasing the initial bead and protein concentrations. If higher 476 
concentrations are being used, the concentration of coupling reagents has to be increased 477 
proportionally to ensure sufficient molar excess. Modifying bead/protein concentrations is 478 
usually a better step towards optimization rather than increasing reaction times. Since the 479 
protocols for bead coupling are lengthy, we commonly prepare a large batch of material. 480 
Aliquots of the suspension can be snap-frozen in liquid nitrogen and stored at -20 °C for several 481 
months. Thawed aliquots should not be refrozen and should be kept at 4 °C and used within 1-2 482 
days. However, this will vary with the nature and stability of the protein used as should be 483 
tested on a small batch initially.  484 
 485 
Bead-coupled adhesins can be used for many applications, as discussed below. This protocol 486 
described an assay that is commonly used to measure inhibition of bacterial binding and 487 
pathogen-mediated cytotoxicity on host cells. The assay is commonly performed to measure 488 
the capacity of bead-coupled MAMs to competitively inhibit infection of Hela epithelial cells 489 
with the sea-food borne pathogen Vibrio parahaemolyticus, using either a decrease in bacterial 490 
attachment to host cells or reduced cytotoxicity as a read-out. In both cases, preparation and 491 
competition assays follow the same protocol. Depending on the readout, different strains of V. 492 
parahaemolyticus are being used: the cytotoxic strain POR1 is used for cytotoxicity 493 
measurements, while the non-cytotoxic strain POR2 is used for measuring bacterial adhesion, 494 
since cell death and cell detachment compromises the procedure for quantifying attached 495 
bacteria.  496 
Initially, competition experiments were set up as a step-wise protocol, where host cells were 497 
first pre-incubated with beads prior to the addition of bacteria. For V. parahaemolyticus and 498 
the bead specifications used (2 m beads coupled to MAM7), both beads and bacteria can be 499 
added at the same time without changes in the resulting cytotoxicity. I.e., in this experimental 500 
setup, beads outcompete bacteria for host cell binding. Depending on the bacterial species and 501 
bead geometry used, there may be good reasons for maintaining the bead adhesion and 502 
bacterial infection as two separate steps. For example, to infect cells with non-motile bacteria, 503 
plates are commonly centrifuged after addition of the infection media. However, centrifugation 504 
of plates containing bead suspensions should be avoided, since this leads to a highly uneven 505 
distribution of beads on the cell layer.  If smaller particle sizes are being used, beads will take 506 
longer to settle on the cell surface, in which case sufficient time should be allowed for bead 507 
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attachment prior to the infection. When bacterial adhesion is used as a read out, samples 508 
should be taken at time points where host cells are not significantly damaged by the infecting 509 
strain, as cell detachment and lysis can compromise the quantification of attached bacteria.  510 
 511 
Instead of enumerating bacterial adhesion by dilution plating, samples may alternatively 512 
be processed for imaging (Figure 5). In this case, tissue culture cells should be seeded onto glass 513 
cover slips, rather than directly into wells. Additionally, fluorescent beads and bacteria 514 
expressing a fluorescent protein may be used, along with infection-specific host cell markers. 515 
For example, competition experiments are commonly imaged using fluorescent red rhodamine-516 
phalloidin to stain the host cells’ actin cytoskelleton and assess morphological changes resulting 517 
from infection, together with fluorescent blue beads and fluorescent green (GFP expressing  or 518 
SYTO18 stained) bacteria.  519 
 520 
A range of bead-coupled adhesins, including Staphylococcus aureus FnBPA, Streptococcus 521 
pyogenes F1 FUD and Vibrio parahaemolyticus MAM, have been used as biomimetic materials 522 
to study adhesion, adhesion inhibition and the contribution of adhesion to pathogen-mediated 523 
cytotoxicity 1, 7, 8. One of the advantages of using this approach is the ease of visualization of 524 
attachment events, since the polymer beads used as scaffolds are available in a wide range of 525 
colors (e.g., blue, fluorescent red, blue, green, orange). Thus, direct protein labeling, which may 526 
interfere with function, can be avoided. Additionally, surface coupling mimics the multivalent 527 
display of adhesins on the bacterial surface, thus reflecting a more physiologically relevant 528 
conformation compared to soluble proteins.  529 
 530 
Compared to studies using intact bacteria or bacterial mutants, the bead approach circumvents 531 
problems associated with bacterial growth. For example, longer-term (e.g., overnight) studies 532 
of bacterial adhesion to host cells using intact bacteria are often compromised by phenomena 533 
accompanying bacterial growth – acidification of the growth medium and nutrient depletion 534 
negatively affect host cells, and bacterial replication eventually compromises imaging quality.  535 
 536 
More recently, the use of bead-coupled adhesins has been extended to include their use as 537 
tools for affinity purifications of host cellular factors involved in signaling processes 538 
downstream of bacterial attachment. V. parahaemolyticus MAM7, via binding to phosphatidic 539 
acids in the host cell membrane, triggers RhoA activation and actin rearrangements 1, 3. MAM-540 
coupled beads are being used to purify and identify proteins involved in the signaling platforms 541 
assembled as a consequence of MAM-host cell binding. Since beads can easily be separated 542 
from the supernatant by a short centrifugation step, and the protein of interest is covalently 543 
coupled, this is a good method to achieve separation from contaminant proteins and enrich 544 
relevant protein complexes, which can be used for downstream applications such as 545 
proteomics or Western Blotting.   546 
 547 
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